Cipla has entered into a joint venture agreement with Kemwell Biopharma on August 25, 2021 for incorporation of a joint venture company for undertaking the business of developing, applying for and obtaining licenses for and manufacturing, commercialising, importing and exporting biologic products and licensing or outsourcing of any or all such activities. The JV Company is being incorporated with an objective to enter the respiratory biosimilars space.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.
